Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)N. Costedoat‐Chalumeau, Alain Dupuy, Jean‐Emmanuel Kahn et al.|Annals of the Rheumatic Diseases|2012Cited by 207
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus ErythematosusM. Jallouli, Lionel Galicier, Noël Zahr et al.|Arthritis & Rheumatology|2015Cited by 140
Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherenceBenoı̂t Blanchet, Aurélien Delluc, M. Jallouli et al.|Arthritis Research & Therapy|2020Cited by 30
Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levelsMeenakshi Jolly, Lionel Galicier, O. Aumaître et al.|Lupus|2016Cited by 19
Therapeutic drug monitoring and clinical outcomes in severely ill patients receiving amoxicillin: a single-centre prospective cohort studyChristophe Marti, Angela Huttner, Jérôme Stirnemann et al.|International Journal of Antimicrobial Agents|2022Cited by 10